Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

A groundbreaking new study has found that a combination of two drugs can boost survival rates in prostate cancer patients by ...

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy.

Medication burden, characterized by polypharmacy and suboptimal treatment adherence, is a predictor for acute care use among ...

The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study finds.

Movember is back. Throughout the month of November, men are skipping their razors in favour of sporting a moustache to help raise money and awareness for men's health issues like mental health and ...

Prostate cancer is the most common cancer in men with 55,300 new cases every year, according to Cancer Research UK ...